Alesia McKeown, PhD, of Roche Diagnostics discusses why pertussis is missed in children and adolescents and how PCR testing can help. Pertussis (whooping cough) is often regarded as a ...

Newborns without intramuscular vitamin K had an adjusted 52% higher odds of any bleeding and nearly 3-fold higher odds of intracranial hemorrhage by 6 months of age. Nonreceipt of intramuscular ...

Nearly 15% of King County children received MMRV as their first measles- or varicella-containing vaccine between 2015 and 2025, a share that did not change despite ACIP's longstanding preference for ...

Pediatric guidance for Deaf and hard-of-hearing children highlights 1-3-6 screening benchmarks, early intervention, early ASL exposure, and timely hearing technology for stronger language outcomes.

A look back at the FDA approvals, label expansions, and regulatory decisions in the pediatric health care space from April through June 2026. Spring gave way to summer, and along the way the FDA kept ...

New AAP guidance recommends age-specific iron deficiency screening, updated ferritin thresholds, and simplified treatment strategies for children. Iron deficiency remains one of the most common ...

A preview of 5 pending FDA decisions for pediatric patients expected in the second half of 2026, spanning ADHD, psoriasis, a metabolic gene therapy, cardiomyopathy, and muscular dystrophy. After a ...

RSV prevention shifts: maternal vaccines and nirsevimab protect infants when timed right, cutting hospitalizations and closing care gaps. Episode 12 addresses the practical question of which infants ...

A look back at the FDA approvals, regulatory decisions, and pipeline updates in the pediatric health care space from June 2026. Another month has come and gone, and with it, several FDA approvals and ...

VCA-894A received FDA rare pediatric disease designation for CMT2S, an ultrarare inherited neuropathy with limited treatment options. The FDA has granted rare pediatric disease designation to VCA-894A ...

Tegacorat received FDA orphan drug and rare pediatric disease designations for Duchenne muscular dystrophy. The FDA has granted orphan drug and rare pediatric disease designations to tegacorat (GRM-01 ...

Explore the heterogeneity of pediatric functional constipation and IBS-C, the limitations of one-size-fits-all algorithms, and the importance of integrating dietary, behavioral, and psychosocial ...